XML 43 R32.htm IDEA: XBRL DOCUMENT
v3.8.0.1

The Business Immunomodulation (Treg Technology) (Details) $ in Millions | 3 Months Ended |  |
--- | --- | --- | ---
Mar. 31, 2016 cohort | May 04, 2017 USD ($) | Feb. 23, 2017 USD ($)
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |
Interim Efficacy Analysis, Percentage Threshold | 50.00% |  |
Interim Efficacy Analysis, Follow-up Milestone Period | 6 years |  |
Grants Receivable |  |  | $ 12.2
Grants Receivable, Current |  | $ 5.7 |
The Sanford Project: T-Rex Study [Member] |  |  |
Research and Development Arrangement, Contract to Perform for Others [Line Items] |  |  |
Number of Cohorts | cohort | 2 |  |

X
- Definition Interim Efficacy Analysis, Follow-up Milestone Period + References No definition available. + Details
Name: | clbs_InterimEfficacyAnalysisFollowupMilestonePeriod
Namespace Prefix: | clbs_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Interim Efficacy Analysis, Percentage Threshold + References No definition available. + Details
Name: | clbs_InterimEfficacyAnalysisPercentageThreshold
Namespace Prefix: | clbs_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of Cohorts + References No definition available. + Details
Name: | clbs_NumberofCohorts
Namespace Prefix: | clbs_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_GrantsReceivable
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Carrying amount as of the balance sheet date of amounts due under the terms of governmental, corporate, or foundation grants. For classified balance sheets, represents the current amount receivable, that is amounts expected to be collected within one year or the normal operating cycle, if longer. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.8) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 + Details
Name: | us-gaap_GrantsReceivableCurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_CapitalizedCostsOfUnprovedPropertiesExcludedFromAmortizationByPropertyOrProjectAxis=clbs_TheSanfordProjectTRexStudyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |